Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

NCT02992964 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02992964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02992964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers
Lead sponsor
The Hospital for Sick Children
Phase
Phase 1/2
Overall status
Terminated
Start date
May 15, 2017
Completion date
November 20, 2023
Enrollment
11 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

biallelic mismatch repair deficiency (bmmrd) positive patients, refractory or recurrent hypermutated malignancies